Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the full year March 31, 2024. For the period, the company expects Net sales of JPY 9,700 million, Operating profit of JPY 1,400 million, Profit of JPY 980 million and Earnings per share of JPY 34.11.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
551 JPY | +0.18% | +0.18% | +7.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.41% | 101M | |
+72.92% | 12.36B | |
-19.68% | 7.83B | |
+16.20% | 7.21B | |
+5.48% | 5.97B | |
+7.49% | 5.14B | |
+23.97% | 4.43B | |
-18.81% | 3.9B | |
-41.54% | 2.2B | |
+2.10% | 2.02B |
- Stock Market
- Equities
- 7775 Stock
- News Daiken Medical Co., Ltd.
- Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Full Year March 31, 2024